- Home
- XTNT vs XCUR Comparison
XTNT vs XCUR Comparison
Compare XTNT & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- XCUR
- Stock Information
- Founded
- XTNT N/A
- XCUR 2011
- Country
- XTNT United States
- XCUR United States
- Employees
- XTNT N/A
- XCUR N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- XCUR Health Care
- Exchange
- XTNT Nasdaq
- XCUR Nasdaq
- Market Cap
- XTNT 60.9M
- XCUR 59.0M
- IPO Year
- XTNT N/A
- XCUR N/A
- Fundamental
- Price
- XTNT $0.74
- XCUR $5.61
- Analyst Decision
- XTNT
- XCUR
- Analyst Count
- XTNT 0
- XCUR 0
- Target Price
- XTNT N/A
- XCUR N/A
- AVG Volume (30 Days)
- XTNT 74.4K
- XCUR 213.9K
- Earning Date
- XTNT 08-07-2025
- XCUR 06-27-2025
- Dividend Yield
- XTNT N/A
- XCUR N/A
- EPS Growth
- XTNT N/A
- XCUR N/A
- EPS
- XTNT N/A
- XCUR N/A
- Revenue
- XTNT $122,298,000.00
- XCUR N/A
- Revenue This Year
- XTNT $11.64
- XCUR N/A
- Revenue Next Year
- XTNT $7.59
- XCUR N/A
- P/E Ratio
- XTNT N/A
- XCUR N/A
- Revenue Growth
- XTNT 20.81
- XCUR N/A
- 52 Week Low
- XTNT $0.33
- XCUR $1.44
- 52 Week High
- XTNT $0.83
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- XTNT 48.39
- XCUR 20.83
- Support Level
- XTNT $0.57
- XCUR $5.42
- Resistance Level
- XTNT $0.65
- XCUR $8.28
- Average True Range (ATR)
- XTNT 0.05
- XCUR 0.76
- MACD
- XTNT -0.01
- XCUR -0.37
- Stochastic Oscillator
- XTNT 33.33
- XCUR 2.32
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.